Evidence map›Paper›PMID 31100059›Full record

ArticlePLoS biology2019

Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.

Suresh Pallikkuth, Lesley R de Armas, Stefano Rinaldi, Varghese K George, Li Pan, Kristopher L Arheart, Rajendra Pahwa, Savita Pahwa

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Human genetics of responses to vaccines.Clinical and experimental immunology · 2025
    Review
  6. Article
  7. Article
  8. Accelerated CD8iScience · 2024
    Article
  9. Article
  10. Destabilisation of T cell-dependent humoral immunity in sepsis.Clinical science (London, England : 1979) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Antigen-Specific CD4Frontiers in immunology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Suresh PallikkuthDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Lesley R de ArmasDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Stefano RinaldiDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Varghese K GeorgeDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Li PanDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Kristopher L ArheartDepartment of Epidemiology and Public Health, Division of Biostatistics, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0001-7699-2278
Rajendra PahwaDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Savita PahwaDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0002-4470-4216
University of Miami · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GWENDOLYN Barbara SCOTT · 2007 to 2026
$33.8M
Antibody Responses in Aging SIV Infected MonkeysR01AI123048 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA, VILLINGER, FRANCOIS J · 2015 to 2019
$4.0M
Antibody Responses in HIV and AgingR01AI108472 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2013 to 2017
$2.9M
NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI108472NIAID NIH HHS R01 AI123048
6 · The paper itself

Abstract

Antigen-primed cluster of differentiation (CD) 4+ T follicular helper (Tfh) cells interact with B cells in the germinal centers (GCs) of lymph nodes to generate vaccine-induced antibody (Ab) responses. In the circulation, peripheral Tfh (pTfh) cells, a subset of memory CD4 T cells, serve as surrogates for GC Tfh because of several functional and phenotypic similarities between them. We investigated features of H1N1 influenza antigen-specific pTfh (Ag.pTfh) in virologically controlled HIV+ volunteers on antiretroviral therapy (ART) and healthy control (HC) participants selected from a seasonal influenza vaccine responsiveness study. Selection of the participants was made based on age, defined as young (18-40 y) and old (>60 y) and on their classification as a vaccine responder (VR) or vaccine nonresponder (VNR). VRs demonstrated expansion of CD40L+ and CD69+ Ag.pTfh, with induction of intracellular interleukin 21 (IL-21) and inducible costimulator (ICOS) post vaccination; these responses were strongest in young HC VRs and were less prominent in HIV+ individuals of all ages. Ag.pTfh in VNRs exhibited dramatically different characteristics from VRs, displaying an altered phenotype and a cytokine profile dominated by cytokines IL-2, tumor necrosis factor alpha (TNF-α), or IL-17 but lacking in IL-21. In coculture experiments, sorted pTfh did not support the B cell IgG production in VNRs and were predominantly an inflammatory T helper 1 (Th1)/T helper 17 (Th17) phenotype with lower ICOS and higher programmed cell death protein 1 (PD1) expression. Induction of IL-21 and ICOS on Ag.pTfh cells are negatively affected by both aging and HIV infection. Our findings demonstrate that dysfunctional Ag.pTfh cells with an altered IL-21/IL-2 axis contribute to inadequate vaccine responses. Approaches for targeting inflammation or expanding functional Tfh may improve vaccine responses in healthy aging and those aging with HIV infection.

Indexed as

AdultAntibodies, ViralAntigens, ViralB-LymphocytesCell ProliferationCytokinesFemaleHIV InfectionsHumansInducible T-Cell Co-Stimulator ProteinInflammation MediatorsInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesInterleukin-2Interleukin-21Antibodies, ViralAntigens, ViralCytokinesInducible T-Cell Co-Stimulator ProteinInflammation MediatorsInfluenza VaccinesInterleukin-2Interleukin-21InterleukinsTumor Necrosis Factor-alpha

Identifiers

PMID31100059
PMCPMC6542545
OpenAlexW2945999367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.